Early antibody responses associated with survival in COVID19 patients

• Zhao-Hua Zhou ,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: Zhaohua.Zhou@fda.hhs.gov (ZZ); Steven.Kozlowski@fda.hhs.gov (SK)

  Affiliation Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring, Maryland, United States of America

  ⨯
• Sai Dharmarajan,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-9287-5810

  ⨯
• Mari Lehtimaki,

  Roles Formal analysis, Writing – review & editing

  Affiliation Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-7869-9064

  ⨯
• Susan L. Kirshner,

  Roles Formal analysis, Writing – review & editing

  Affiliation Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-3265-4805

  ⨯
• Steven Kozlowski

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: Zhaohua.Zhou@fda.hhs.gov (ZZ); Steven.Kozlowski@fda.hhs.gov (SK)

  Affiliation Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-7240-3605

  ⨯